2016-2020 Japan Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
Complete report $8,850. DataPack (test volumes, sales forecasts, supplier shares) $5,700.
VPGMarketResearch.com's new report is an analysis of major business opportunities emerging in the Japanese automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.
The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding Japanese microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Market Segmentation Analysis
Sales and market shares for major suppliers by individual test.
Volume and sales forecasts for over 100 infectious disease assays by individual test:
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Technology Review
Opportunities and Strategic Recommendations
VPGMarketResearch.com's new report is an analysis of major business opportunities emerging in the Japanese automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.
The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding Japanese microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Market Segmentation Analysis
Sales and market shares for major suppliers by individual test.
Volume and sales forecasts for over 100 infectious disease assays by individual test:
- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
- Review of the market dynamics, trends, structure, size, growth and major suppliers.
- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva
- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Cultures
- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
- The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Technology Review
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
- Global listings of companies developing or marketing microbiology products by individual test.
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
Opportunities and Strategic Recommendations
- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
I. The Bimodal Trend
II. Consolidation
III. Major Geographic Regions
IV. Major Product Categories
A. Flavors
1. BEVERAGES/JUICES
2. REACTION FLAVORS
3. SWEETS
4. SAVORY
5. ENZYMES
6. TOBACCO
7. PHARMACEUTICALS
8. OTHERS
B. Fragrances
1. DETERGENTS AND SOAPS
2. FINE FRAGRANCES
3. COSMETICS
4. HOUSEHOLD PRODUCTS
5. OTHER
C. Aroma Chemicals
1. SYNTHETIC FRAGRANCE CHEMICALS
2. SYNTHETIC FLAVOR CHEMICALS
D. Essential Oils
E. Strategic Directions
Business goals and strategies, including internal expansion, acquisitions, and divestitures.
Specific business, new product development and marketing objectives and strategies.
Major strengths and weaknesses.
Anticipated acquisitions, joint ventures and divestitures.
F. Marketing Tactics
Sales force estimates by country
Major sales office locations
Distribution strategies
Promotional tactics.
G. Technological Know-How
Products and services, including fragrances (fine, technical), flavors, aroma chemicals (high-volume standard products, high-volume specialties, low-volume specialties), essential oils, and others
Know-how in chemical technology, biotechnology, aromacology and related fields.
II. Consolidation
III. Major Geographic Regions
IV. Major Product Categories
A. Flavors
1. BEVERAGES/JUICES
2. REACTION FLAVORS
3. SWEETS
4. SAVORY
5. ENZYMES
6. TOBACCO
7. PHARMACEUTICALS
8. OTHERS
B. Fragrances
1. DETERGENTS AND SOAPS
2. FINE FRAGRANCES
3. COSMETICS
4. HOUSEHOLD PRODUCTS
5. OTHER
C. Aroma Chemicals
1. SYNTHETIC FRAGRANCE CHEMICALS
2. SYNTHETIC FLAVOR CHEMICALS
D. Essential Oils
E. Strategic Directions
Business goals and strategies, including internal expansion, acquisitions, and divestitures.
Specific business, new product development and marketing objectives and strategies.
Major strengths and weaknesses.
Anticipated acquisitions, joint ventures and divestitures.
F. Marketing Tactics
Sales force estimates by country
Major sales office locations
Distribution strategies
Promotional tactics.
G. Technological Know-How
Products and services, including fragrances (fine, technical), flavors, aroma chemicals (high-volume standard products, high-volume specialties, low-volume specialties), essential oils, and others
Know-how in chemical technology, biotechnology, aromacology and related fields.
LIST OF TABLES
Table 1: World Flavor and Fragrance Market Forecast by Geographic Region
Table 2: World Flavor and Fragrance Market Forecast by Product Category
Table 1: World Flavor and Fragrance Market Forecast by Geographic Region
Table 2: World Flavor and Fragrance Market Forecast by Product Category
